title: A regulatory circuit mediating convergence between Nurr1 transcriptional regulation and Wnt signaling.
abstract: The orphan nuclear receptor Nurr1 is essential for the development and maintenance of midbrain dopaminergic neurons, the cells that degenerate during Parkinson's disease, by promoting the transcription of genes involved in dopaminergic neurotransmission. Since Nurr1 lacks a classical ligand-binding pocket, it is not clear which factors regulate its activity and how these factors are affected during disease pathogenesis. Since Wnt signaling via beta-catenin promotes the differentiation of Nurr1(+) dopaminergic precursors in vitro, we tested for functional interactions between these systems. We found that beta-catenin and Nurr1 functionally interact at multiple levels. In the absence of beta-catenin, Nurr1 is associated with Lef-1 in corepressor complexes. Beta-catenin binds Nurr1 and disrupts these corepressor complexes, leading to coactivator recruitment and induction of Wnt- and Nurr1-responsive genes. We then identified KCNIP4/calsenilin-like protein as being responsive to concurrent activation by Nurr1 and beta-catenin. Since KCNIP4 interacts with presenilins, the Alzheimer's disease-associated proteins that promote beta-catenin degradation, we tested the possibility that KCNIP4 induction regulates beta-catenin signaling. KCNIP4 induction limited beta-catenin activity in a presenilin-dependent manner, thereby serving as a negative feedback loop; furthermore, Nurr1 inhibition of beta-catenin activity was absent in PS1(-/-) cells or in the presence of small interfering RNAs specific to KCNIP4. These data describe regulatory convergence between Nurr1 and beta-catenin, providing a mechanism by which Nurr1 could be regulated by Wnt signaling.
authors: Department of Molecular Endocrinology, Merck Research Laboratories, West Point, Pennsylvania 19486, USA.
authors: Hirochika
authors: H
authors: Kitagawa
authors: William J
authors: WJ
authors: Ray
authors: Helmut
authors: H
authors: Glantschnig
authors: Pascale V
authors: PV
authors: Nantermet
authors: Yuanjiang
authors: Y
authors: Yu
authors: Chih-Tai
authors: CT
authors: Leu
authors: Shun-ichi
authors: S
authors: Harada
authors: Shigeaki
authors: S
authors: Kato
authors: Leonard P
authors: LP
authors: Freedman
mesh_terms: D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D002467:Cell Nucleus / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000235:genetics* / Q000378:metabolism*; D005786:Gene Expression Regulation; D053263:Gene Regulatory Networks; D051605:Kv Channel-Interacting Proteins / Q000378:metabolism; D051821:Lymphoid Enhancer-Binding Factor 1 / Q000378:metabolism; D051379:Mice; D008954:Models, Biological; D008969:Molecular Sequence Data; D057126:Nuclear Receptor Subfamily 4, Group A, Member 2; D053764:Presenilin-1 / Q000378:metabolism; D011485:Protein Binding; D011499:Protein Processing, Post-Translational; D051381:Rats; D012097:Repressor Proteins / Q000378:metabolism; D015398:Signal Transduction; D014157:Transcription Factors / Q000235:genetics* / Q000378:metabolism*; D014158:Transcription, Genetic; D051153:Wnt Proteins / Q000378:metabolism*; D051176:beta Catenin / Q000378:metabolism
chemical_list: D004268:DNA-Binding Proteins; C496753:KCNIP4 protein, human; D051605:Kv Channel-Interacting Proteins; C497575:Lef1 protein, rat; D051821:Lymphoid Enhancer-Binding Factor 1; C539882:NR4A2 protein, human; C539883:Nr4a2 protein, mouse; C539884:Nr4a2 protein, rat; D057126:Nuclear Receptor Subfamily 4, Group A, Member 2; D053764:Presenilin-1; D012097:Repressor Proteins; D014157:Transcription Factors; D051153:Wnt Proteins; D051176:beta Catenin
references: Biol Psychiatry. 2005 Mar 1;57(5):533-42
references: 15737669
references: J Biol Chem. 2004 Dec 17;279(51):53338-45
references: 15456745
references: Nat Rev Mol Cell Biol. 2005 Jul;6(7):542-54
references: 15957004
references: Biochem J. 2005 Sep 15;390(Pt 3):749-59
references: 15910281
references: J Neurochem. 2005 Oct;95(2):513-25
references: 16144542
references: J Comp Neurol. 2006 Jan 20;494(3):495-514
references: 16320253
references: Endocr Rev. 2005 Dec;26(7):898-915
references: 16126938
references: Endocrinology. 2006 Jan;147(1):141-54
references: 16210377
references: J Biol Chem. 2006 Feb 3;281(5):2676-82
references: 16293616
references: J Cell Sci. 2006 Feb 1;119(Pt 3):395-402
references: 16443747
references: Mol Cell Neurosci. 2006 Feb;31(2):251-62
references: 16243537
references: Genes Dev. 2006 Mar 1;20(5):586-600
references: 16510874
references: J Neurosci. 2006 Apr 26;26(17):4567-76
references: 16641236
references: Int J Neuropsychopharmacol. 2006 Jun;9(3):337-42
references: 16191209
references: J Biol Chem. 2006 Jun 30;281(26):17856-63
references: 16644723
references: Mol Cell Biol. 2006 Aug;26(15):5827-37
references: 16847334
references: Neurodegener Dis. 2006;3(1-2):5-11
references: 16909030
references: J Mol Endocrinol. 2006 Oct;37(2):317-26
references: 17032747
references: Nucleic Acids Res. 2006;34(19):5515-27
references: 17020917
references: Nat Struct Mol Biol. 2005 Apr;12(4):364-71
references: 15768032
references: Exp Neurol. 2005 Jan;191(1):154-62
references: 15589522
references: J Biol Chem. 1999 Dec 24;274(52):37483-90
references: 10601324
references: J Neurochem. 2001 Mar;76(5):1565-72
references: 11238740
references: J Cell Biol. 2001 Feb 19;152(4):785-94
references: 11266469
references: Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10863-8
references: 11517342
references: J Cell Sci. 2001 Jul;114(Pt 13):2363-73
references: 11559745
references: J Biol Chem. 2001 Oct 19;276(42):38563-9
references: 11504726
references: Nat Cell Biol. 2001 Nov;3(11):1030-3
references: 11715026
references: J Biol Chem. 2001 Dec 21;276(51):48554-61
references: 11606587
references: Postgrad Med J. 2002 Mar;78(917):142-8
references: 11884695
references: Mol Cell. 2002 Mar;9(3):553-62
references: 11931763
references: J Biol Chem. 2002 Apr 26;277(17):14965-75
references: 11847232
references: J Biol Chem. 2002 Sep 6;277(36):33001-11
references: 12082103
references: J Comp Neurol. 2002 Aug 26;450(3):203-14
references: 12209851
references: Cell. 2002 Sep 20;110(6):751-62
references: 12297048
references: Neuroscientist. 2002 Oct;8(5):497-511
references: 12374432
references: Nat Genet. 2003 Jan;33(1):85-9
references: 12496759
references: Mol Cell Biol. 2003 Feb;23(3):763-76
references: 12529383
references: Neuropathology. 2002 Dec;22(4):219-32
references: 12564761
references: J Neurochem. 2003 May;85(3):622-34
references: 12694388
references: Nature. 2003 May 29;423(6939):555-60
references: 12774125
references: Cell. 2003 Jun 27;113(7):905-17
references: 12837248
references: Exp Cell Res. 2003 Aug 15;288(2):324-34
references: 12915123
references: Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12747-52
references: 14557550
references: Biochem Biophys Res Commun. 2004 Jan 2;313(1):205-11
references: 14672718
references: Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15619-24
references: 14671317
references: J Biol Chem. 2004 Jan 9;279(2):1310-22
references: 14576152
references: J Biol Chem. 2004 Jan 16;279(3):2005-11
references: 14559918
references: J Neurochem. 2004 Mar;88(5):1283-94
references: 15009684
references: J Neurosci. 2004 Jun 30;24(26):5922-30
references: 15229240
references: Mol Endocrinol. 2004 Aug;18(8):2011-23
references: 15131260
references: J Biol Chem. 2004 Sep 24;279(39):40255-8
references: 15304487
references: Cell. 1995 May 19;81(4):541-50
references: 7758108
references: Nature. 1996 Sep 26;383(6598):332-4
references: 8848044
references: Mol Endocrinol. 1997 Jan;11(1):39-47
references: 8994186
references: Science. 1997 Apr 11;276(5310):248-50
references: 9092472
references: Oncogene. 1997 Dec 4;15(23):2833-9
references: 9419974
references: Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):4013-8
references: 9520484
references: Development. 1999 Sep;126(18):4017-26
references: 10457011